Physician profile
Daniel Haber
NPI 1932513058
$25,354.82
in general payments reported to CMS, 2019-2025
11 companies · $410 in 2025
The $410 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,492 · 2020: $22K · 2021: $397 · 2022: $77.25 · 2023: $120 · 2024: $592 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $797 · Travel and Lodging: $324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $796.88 |
| Travel and Lodging | $324.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $20,000.00 | 2020 | |
| Djo, LLC | $2,187.49 | 2019-2020 | |
| Stryker Corporation | $1,190.18 | 2020-2025 | Blueprint Patient Specific Instrumentation, 1788, Aequalis Ascend Flex |
| Gemini Mountain Medical, LLC | $835.76 | 2020 | |
| Smith+Nephew, INC. | $665.09 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $236.05 | 2021-2025 | Comprehensive Shoulder System, Tricera Handpiece |
| Depuy Synthes Sales INC. | $112.49 | 2021-2024 | Motoband, Lcp |
| Nevro Corp. | $57.76 | 2024 | Senza |
| Bioventus LLC | $32.47 | 2021-2023 | Exogen Ultrasound Bone Healing System |
| Vericel Corporation | $22.10 | 2025 | Maci |
| Vertex Pharmaceuticals Incorporated | $15.43 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Haber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.